Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
First patient treated with Cu-67 SAR-Bombesin in theranostic prostate cancer trial
2023-10-03 20:58
Caliway's CBL-514 Achieved Better Efficacy than Liposuction, Reducing over 300mL of Subcutaneous Fat on Average in CBL-0202 Study
2023-10-02 21:00
Flat Medical Secures Series C Funding Led by Taiwania Capital, Poised for Global Market Expansion
2023-10-02 20:30
Jin Medical International Limited Receives NASDAQ Notification Letter Regarding Noncompliance with Continued Listing Rule 5550(a)(3)
2023-09-29 04:30
SGC and HitGen Announce Research Collaboration Focused on DNA-Encoded Library Based Drug Discovery
2023-09-28 21:30
ProfoundBio Announces Upcoming Scientific Presentations at SITC 2023
2023-09-28 20:00
Mabwell Announces First Patient Dosed in Phase Ib/II Trial of its Novel Nectin-4 Targeting ADC in Combination with PD-1 Inhibitor
2023-09-28 20:00
IASO Bio Presents Updated Long-Term Follow-Up Data for BCMA CAR-T FUCASO® (Equecabtagene Autoleucel) at IMS 2023
2023-09-28 18:09
Akeso Announced FDA Clearance of IND for CD47 Monoclonal Antibody (AK117) in Combination with Azacitidine in Myelodysplastic Syndromes
2023-09-28 10:07
BioCity Signs Collaboration Agreement with AstraZeneca on BC3402, a monoclonal antibody targeting anti-TIM-3, in Combination with IMFINZI (durvalumab) for the Treatment of Advanced Hepatocellular Carcinoma in China
2023-09-28 09:46
OBiO has launched its state-of-the-art GMP production facility Intelli-M to expedite innovative and advanced therapies to patients who are in need.
2023-09-27 21:00
SK Biopharmaceuticals' Proteovant Therapeutics Presents Preclinical Data on IKZF2 Protein Degrader Program and MOPED™ Molecular Glue Screening Platform at the 20th Annual Discovery on Target Conference
2023-09-27 08:30
ABM Therapeutics' ABM-1310 Granted Fast Track Designation by the FDA Following Orphan Drug Designation
2023-09-27 00:00
China Jo-Jo Drugstores Announces $2.59 Million Registered Direct Offering
2023-09-26 21:00
Actinogen optimizes XanaMIA Phase 2b Alzheimer's disease trial design and provides general business update
2023-09-26 20:51
WuXi Vaccines Launches Its First Vaccines CDMO Site in China
2023-09-26 15:41
Chinese Patent Granted for CytoMed Therapeutics' Licensed iPSC-Based Technology
2023-09-25 19:00
MediLink Therapeutics: Focuses on ADC research and development to promote new prospects for cancer treatment
2023-09-23 18:29
FDA Grants Fast Track Designation to 9MW3011
2023-09-22 08:00
Inmagene announces formation of Celexor Bio based on its anti-ILT7 mAb with enhanced pDC depletion function
2023-09-21 21:00
1
19
20
21
22
23
148